A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

This publication has 15 references indexed in Scilit:

• Combining pioglitazone with a sulphonylurea or metformin in the management of type 2 diabetes
  Experimental and Clinical Endocrinology & Diabetes, 2000
• Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study
  Clinical Therapeutics, 2000
• Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
  Diabetes Care, 2000
• Rosiglitazone and pioglitazone: two new thiazolidinediones
  Practical Diabetes International, 2000
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• “Glitazones”, a prospect for non-insulin-dependent diabetes
  The Lancet, 1997
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group
  Diabetes, 1995
• Methodologic guidelines for systematic reviews of randomized control trials in health care from the potsdam consultation on meta-analysis
  Journal of Clinical Epidemiology, 1995
• Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes
  BMJ, 1994